In yesterday’s Wall Street session, MAIA Biotechnology Inc (AMEX:MAIA) shares traded at $2.00, up 5.82% from the previous session.
MAIA stock price is now -2.96% away from the 50-day moving average and -29.35% away from the 200-day moving average. The market capitalization of the company currently stands at $50.66M.
In other news, Smith Stan, Director bought 25,000 shares of the company’s stock on Dec 13 ’24. The stock was bought for $46,800 at an average price of $1.87. Upon completion of the transaction, the Director now directly owns 1,130,060 shares in the company, valued at $2.26 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 13 ’24, Director Guerrero Ramiro bought 53,418 shares of the business’s stock. A total of $99,998 was incurred on buying the stock at an average price of $1.87. This leaves the insider owning 514,970 shares of the company worth $1.03 million. A total of 16.87% of the company’s stock is owned by insiders.
During the past 12 months, MAIA Biotechnology Inc has had a low of $1.24 and a high of $5.99. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 2.56, and a quick ratio of 2.56. The fifty day moving average price for MAIA is $2.0648 and a two-hundred day moving average price translates $2.83087 for the stock.
The latest earnings results from MAIA Biotechnology Inc (AMEX: MAIA) was released for 2024-06-30. The company reported revenue of $4.19 million for the quarter, compared to $4.96 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -15.48 percent.